FGFR3-TACC3 fusion resulted in the loss of miR99a, promoted cell proliferation and tumor progression in GBM cultures and xenograft mice, co-existing with amplification of EGFR, PDGFR, or MET genes [24]. The gene discussed is EGFR; the disease is glioblastoma.